Navigation Links
Avisena Announces Major Increases in Profit for Second Quarter 2009
Date:8/18/2009

Revenue Cycle Management Specialists, Avisena, Announces Increased Earnings for the Second Quarter, Including Positive Operating Profit for the Year-to-Date.

Miami, FL (PRWEB) August 18, 2009 -- Avisena, Inc., a revenue cycle management (RCM) company servicing the health care industry that offers a proprietary, Internet-based technology platform, announced strong second quarter results driven by a growing demand in healthcare practice management solutions. Avisena cites consistent sales productivity, technology enhancements as well as operational improvements as the reason for the companies continued financial success.

Operating profit was up 148 percent compared to the same quarter in 2008. Avisena continues to thrive in the midst of a struggling US (Global) economy and is well on track to deliver an eighth consecutive year of steady financial growth.

"Even in these economically difficult times, Avisena is continually hiring and creating opportunities in the communities we do business; we also are increasing shareholder value by steady growth and projected increases in revenue," said Mike Maseda, Avisena President and CEO. "Avisena has experienced a 20 percent growth in year-to-date claims revenue from '08 to '09. These metrics can be attributed to our continued innovation, relentless focus on client service, and superior client collection results," explained Maseda.

According to the Medical Group Management Association 73 percent of practices are dealing with operating costs that are rising more rapidly than revenue. Traditionally run medical practices are being squeezed by increasing cost pressure coupled with declining payer reimbursement resulting in significant reduction in profits. In order to combat these on-going trends, practices are turning to Avisena's Software Enabled Service (SES) model for more efficient and cost effective solutions to reduce expenses and increase revenues.

"Physicians are asking how they can save money and do more with decreasing revenue," said Maseda. "Avisena is uniquely positioned to help our customers save money by offering advanced technologies that will help physicians streamline the payer reimbursement process. It is commonplace for Avisena clients to experience 10% to 20% revenue growth while simultaneously reducing their expenses to their bottom-line."

In addition to notable increase in profits, Q2 presented Avisena with national recognition for its economic consistency and growth in recent years. Accolades include ranking as the 1,018 fastest-growing company in Inc 500/5000 2009 list as well as local recognition as the Greater Miami Chamber of Commerce's "Good to Great Business in the 51-249 employee category" and the South Florida Business Journal "Business of the Year."

About Avisena:
Avisena is a revenue cycle management company that helps medical practices improve collections through the use of its Internet-based medical billing software technology and practice management expertise. By streamlining front and back office processes, Avisena helps medical practices Collect More, Spend Less and Live Better. Visit Avisena online at http://www.avisena.com.

# # #

Read the full story at http://www.prweb.com/releases/revenuecyclemanagement/avisena/prweb2748704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share Repurchase
2. Accelify Announces Training Dates for Missouri Medicaid Consortium
3. Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024
4. Gaiam Announces New Deal With Valerie Bertinelli
5. MHA Announces Gloria Barr, Esq. as Vice President & General Counsel
6. LifeCare Holdings, Inc. Announces Second Quarter Results
7. Secretary Shinseki Announces Expansion of Counseling for Combat Veterans
8. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter Fiscal 2010 Financial Results
9. Purple Communications(TM) Announces Second Quarter 2009 Results
10. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
11. Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... , ... David J. Dykeman , Ginger Pigott , and ... at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg ... global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to ... convenient service for Texas, they are expanding their presence in Dallas. One of the ... that will bring new jobs to the Dallas and Forth Worth market. STAT takes ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and the Affordable Care Act. Dr. Botelho advocates for the mass media launching ... movement gives people ongoing opportunities to share their unfortunate experiences; such a movement ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology: